drugset / Trial / NCT00912860
Immunogenicity and Safety Study of Serum-Free Avonex
NaSingle-groupOpen-labelBasic science
Summary
To evaluate the immunogenicity of a serum-free pre-formulated solution of Avonex when given to interferon beta naive patients with relapsing/remitting multiple sclerosis.
Timeline
- Start
- 2003-01
- Primary completion
- 2004-12
- Completion
- 2005-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Interferon beta-1a | Protein / enzyme biologic | — | Intramuscular |